We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$24.2M
2
BLU
BELLUS Health Inc.
BLU
+$16.7M
3
ABUS icon
Arbutus Biopharma
ABUS
+$11.7M
4
NKLAW
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
+$11M
5
LGVW.U
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BABA icon
26
Alibaba
BABA
$317B
$4.43M 0.72%
15,070
-425
-3% -$112K
GOAC.U
27
DELISTED
GO Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of on
GOAC.U
$4.2M 0.69%
+411,339
New +$4.12M
QGEN icon
28
Qiagen
QGEN
$9.04B
$4.13M 0.67%
74,543
-10,335
-12% -$536K
BPYU
29
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$3.82M 0.62%
+312,370
New +$3.58M
CVNA icon
30
CALL
Carvana
CVNA
$81.5B
$3.75M 0.61%
125,000
– –
UNP icon
31
Union Pacific
UNP
$174B
$3.57M 0.58%
+18,155
New +$3.37M
VMACU
32
DELISTED
Vistas Media Acquisition Company Inc. Unit
VMACU
$3.23M 0.53%
+320,296
New +$3.2M
XGN icon
33
Exagen
XGN
$161M
$3.18M 0.52%
293,339
-139,063
-32% -$1.79M
FCX icon
34
Freeport-McMoran
FCX
$98.7B
$3.11M 0.51%
199,030
+47,934
+32% +$692K
KSMTU
35
DELISTED
Kismet Acquisition One Corp Unit
KSMTU
$2.78M 0.45%
+277,796
New +$2.79M
BBVA icon
36
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
$2.74M 0.45%
1,000,000
– –
CMRC
37
PUT
Commerce.com Inc Series 1
CMRC
$175M
$2.67M 0.44%
+70,100
New +$6.13M
PANA.U
38
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$2.6M 0.42%
+216,658
New +$2.49M
RPV icon
39
Invesco S&P 500 Pure Value ETF
RPV
$1.72B
$2.5M 0.41%
51,000
-10,000
-16% -$498K
JIH
40
DELISTED
Juniper Industrial Holdings, Inc.
JIH
$2.49M 0.41%
+238,294
New +$2.42M
RPG icon
41
Invesco S&P 500 Pure Growth ETF
RPG
$2.03B
$2.47M 0.4%
95,500
-86,000
-47% -$2.39M
BWAY
42
Brainsway
BWAY
$615M
$2.44M 0.4%
835,372
+17,620
+2% +$55.6K
CVX icon
43
Chevron
CVX
$382B
$2.34M 0.38%
+32,503
New +$2.73M
CHNGU
44
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
$2.34M 0.38%
43,796
+1,000
+2% +$48K
WMGI
45
DELISTED
Wright Medical Group Inc
WMGI
$2.31M 0.38%
+75,500
New +$2.28M
APYX icon
46
Apyx Medical
APYX
$146M
$2.28M 0.37%
484,246
+30,948
+7% +$153K
SMH icon
47
CALL
VanEck Semiconductor ETF
SMH
$70.1B
$2.27M 0.37%
+138,400
New +$11.6M
NAV
48
CALL
DELISTED
Navistar International
NAV
$2.18M 0.36%
164,600
+68,200
+71% +$2.34M
ETACU
49
DELISTED
E.Merge Technology Acquisition Corp. Unit
ETACU
$2.1M 0.34%
+208,411
New +$2.09M
TARA icon
50
Protara Therapeutics
TARA
$231M
$2.09M 0.34%
+124,171
New +$2.88M
1
2
3 4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.